Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03907176 · ClinicalTrials.gov registry record · Phase 3
Study of Post-Herniorrhaphy Non-opioid MMA Regimens
A Phase 3 study, sponsored by Heron Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 209
- Enrollment target
NCT03907176 is a Phase 3 study that has completed, run by Heron Therapeutics. The registered enrollment target is 209 participants.
The verdict
NCT03907176, a Phase 3 study, has completed, sponsored by Heron Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 209 participants
- Enrollment target
Study Summary
This is a Phase 3b, open-label study to assess postoperative opioid use in subjects undergoing unilateral open inguinal herniorrhaphy with intraoperative administration of HTX-011 and a postoperative non-opioid multimodal analgesic (MMA) regimen. The study will be conducted in 2 sequential parts: Part 1 is randomized and Part 2 is Investigator's preference for MMA regimen.
Interventions
- DRUG Acetaminophen
- DRUG Ibuprofen
- DRUG HTX-011
- DEVICE Luer lock applicator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2019-04-04 |
| Est. Completion | 2021-11-22 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03907176
The ClinicalTrials.gov registry entry for NCT03907176 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 209 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Heron Therapeutics, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Acetaminophen is the first listed.
NCT03907176 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03907176 about?
NCT03907176 is a clinical study titled "Study of Post-Herniorrhaphy Non-opioid MMA Regimens". This is a Phase 3b, open-label study to assess postoperative opioid use in subjects undergoing unilateral open inguinal herniorrhaphy with intraoperative administration of HTX-011 and a postoperative non-opioid multimodal analgesic (MMA) regimen. The study will be conducted in 2 sequential parts: Pa...
What is the current status of trial NCT03907176?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 209 participants. The study started on 2019-04-04. Estimated completion is 2021-11-22.
What interventions are being tested in trial NCT03907176?
The interventions under investigation include: Acetaminophen (DRUG), Ibuprofen (DRUG), HTX-011 (DRUG), Luer lock applicator (DEVICE).
Who is sponsoring clinical trial NCT03907176?
This trial is sponsored by Heron Therapeutics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.